Suppressive effect of portal venous inoculation with tumor cells on the anti-tumor immune potentialKOKUDO, S; JIA-HUA QIAN; FUJIWARA, H et al.Japanese journal of cancer research. 1987, Vol 78, Num 9, pp 946-951, issn 0910-5050Article

TUMOUR-DERIVED LYMPHOID CELLS PREVENT TUMOUR GROWTH IN WINN ASSAYSROBINS RA; FLANNERY GB; BALDWIN RW et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 40; NO 6; PP. 946-949; BIBL. 10 REF.Article

Detection and characterization of anti-tumour effector cells in Meth-A-bearing mice treated with recombinant human interleukin 2NARUO, K.-I; HINUMA, S; SHIHO, O et al.Clinical and experimental immunology (Print). 1989, Vol 76, Num 2, pp 278-283, issn 0009-9104, 6 p.Article

THE EFFECT OF CORYNEBACTERIUM PARVUM ON T CELL DEPENDENT TUMOR REGRESSIONMCBRIDE WH; PETERS LJ; MASON KA et al.1980; J. RETICULOENDOTHEL. SOC.; USA; DA. 1980; VOL. 27; NO 2; PP. 151-158; BIBL. 26 REF.Article

TRANSFER OF RESISTANCE AGAINST A TRANSPLANTABLE BALB/C LYMPHOMAWEDDERBURN N; CAMPA M; CARTER RL et al.1980; EUROP. J. CANCER; GBR; DA. 1980; VOL. 16; NO 3; PP. 375-381; BIBL. 20 REF.Article

EFFECTOR AND ENHANCING LYMPHOID CELLS IN PLASMACYTOMA-BEARING MICE. I: METHODOLOGICAL STUDIES ON THE WINN ASSAYWANG KC; BERCZI I; SEHON AH et al.1980; INTERNATIONAL. J. CANCER; CHE; DA. 1980; VOL. 25; NO 4; PP. 487-492; BIBL. 2 P.Article

EFFECTOR AND ENHANCING LYMPHOIDS CELLS IN PLASMACYTOMA-BEARING MICE. II: DYNAMIC CHANGES DURING TUMOR PROGRESSIONWANG KC; BERCZI I; HOFFMANN EG et al.1980; INTERNATIONAL. J. CANCER; CHE; DA. 1980; VOL. 25; NO 4; PP. 493-501; BIBL. 35 REF.Article

The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigensSANO, S; IZUMI, Y; SUGIHARA, S et al.Cancer immunology and immunotherapy. 1987, Vol 25, Num 2, pp 105-110, issn 0340-7004Article

The role of idiotype-specific, CD4⁺ T cells in tumor resistance against major histocompatibility complex mass II molecule negative plasmacytoma cellsLAURITZSEN, G. F; BOGEN, B.Cellular immunology (Print). 1993, Vol 148, Num 1, pp 177-188, issn 0008-8749Article

Significance of suppressor macrophages for immunosurveillance of tumor-bearing miceFUJII, T; IGARASHI, T; KISHIMOTO, S et al.Journal of the National Cancer Institute. 1987, Vol 78, Num 3, pp 509-517, issn 0027-8874Article

Implantation of a gelatin-sponge as a model for effector recruitment: tumor growth inhibition by T-lymphocytes recovered from a site of tumor rejectionAKPORIAYE, E. T; KUDALORE, M. K.Cancer immunology and immunotherapy. 1989, Vol 29, Num 3, pp 199-204, issn 0340-7004, 6 p.Article

Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in miceDENT, L. A; SPENCER, L. K; ATTRIDGE, S et al.Immunology and cell biology. 1989, Vol 67, pp 403-412, issn 0818-9641, 10 p., 6Article

Increased production of cytotoxic macrophage progenitors by Lactobacillus casei in miceNANNO, M; SHIMIZU-TAKEDA, T; MIKE, A et al.Journal of leukocyte biology. 1989, Vol 46, Num 2, pp 89-95, issn 0741-5400Article

Differential ability of tumor-unique and cross-reactive antigen (s) on two murine hepatoma cell lines to induce Lyt-1⁺2^-T cells responsible for in vivo protective immunitySHIMA, J; YOSHIOKA, T; KOSUGI, A et al.Biken journal. 1987, Vol 30, Num 1, pp 1-8, issn 0006-2324Article

Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4⁺ T cellsOZAWA, H; IWAGUCHI, T; KATAOKA, T et al.The Journal of immunology (1950). 1987, Vol 139, Num 11, pp 3896-3901, issn 0022-1767Article